Active Lifestyles And New Surgical Techniques Driving Sports Medicine Market
This article was originally published in The Gray Sheet
Although the U.S. market for sports medicine products is dominated by conservative care products, new surgical techniques and products, including arthroscopy products and surgical implants, are fueling growth in the market, which is projected to reach almost $15.5 billion by 2018.
You may also be interested in...
The sports medicine market comprises a number of product segments, many of which span several different orthopedics specialties.This space is expected to experience strong growth going forward as companies develop innovative ways, including some lower-cost approaches, to treat the joint and soft-tissue injuries commonly suffered by athletes and other sports enthusiasts.
SK Bioscience has received the world’s first approval of its in-house developed recombinant protein COVID-19 vaccine SKYCovione (GBP510), in its home market of South Korea, two years after it began development. Strong support from the domestic government and international cooperation helped pave the way.
Can-Fite’s A3AR agonist was inferior to Amgen’s Otezla by most efficacy measures, while Bristol Myers Squibb’s competing deucravacitinib is closer to approval and did beat Otezla.